tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Smart Growth
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News WireArrivedEquityMultiple
Follow Us
TOOLS
News
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Most Visited Websites
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Class Actions
Class Actions
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us

KYTX Stock Latest News

Company AnnouncementsKyverna Therapeutics Sets 2025 Strategic Priorities for Growth
5d ago
8K
KYTX
Kyverna Therapeutics announces senior leadership appointments
PremiumThe Fly
Kyverna Therapeutics announces senior leadership appointments
1M ago
KYTX
PremiumClass Action
Lost Money on Kyverna Therapeutics, Inc.(KYTX)? Join Class Action Suit Seeking Recovery – Contact Levi & Korsinsky LLP
1M ago
KYTX
JPMorgan healthcare analysts hold an analyst/industry conference call
PremiumThe Fly
JPMorgan healthcare analysts hold an analyst/industry conference call
1M ago
ALLO
IGMS
Kyverna shares remain ‘significantly under-valued,’ says JPMorgan
PremiumThe Fly
Kyverna shares remain ‘significantly under-valued,’ says JPMorgan
2M ago
KYTX
PremiumCompany AnnouncementsKyverna CMO Resignation Highlights Leadership Transition Impact
2M ago
8K
KYTX
Kyverna Therapeutics price target lowered to $6 from $7 at H.C. Wainwright
Premium
The Fly
Kyverna Therapeutics price target lowered to $6 from $7 at H.C. Wainwright
2M ago
KYTX
Kyverna Therapeutics price target lowered to $24 from $44 at Wells Fargo
Premium
The Fly
Kyverna Therapeutics price target lowered to $24 from $44 at Wells Fargo
2M ago
KYTX
PremiumCompany Announcements
Kyverna Therapeutics Reports Q3 Loss Amid Rising R&D Costs
2M ago
KYTX
Kyverna Therapeutics anounces patient data on KYV-101
PremiumThe Fly
Kyverna Therapeutics anounces patient data on KYV-101
2M ago
KYTX
PremiumCompany Announcements
Kyverna Therapeutics Advances in Cell Therapy Leadership
2M ago
8K
KYTX
Kyverna Therapeutics reports Q3 EPS (80c), consensus (79c)
PremiumThe Fly
Kyverna Therapeutics reports Q3 EPS (80c), consensus (79c)
2M ago
KYTX
PremiumCompany AnnouncementsKyverna Therapeutics Strengthens Board with New Appointment
3M ago
8K
KYTX
Kyverna Therapeutics initiated with a Buy at UBS
Premium
The Fly
Kyverna Therapeutics initiated with a Buy at UBS
3M ago
KYTX
Kyverna Therapeutics initiated with a Buy at Rodman & Renshaw
Premium
The Fly
Kyverna Therapeutics initiated with a Buy at Rodman & Renshaw
3M ago
KYTX
Kyverna treatment of systemic sclerosis granted FDA orphan designation
PremiumThe Fly
Kyverna treatment of systemic sclerosis granted FDA orphan designation
4M ago
KYTX
Kyverna announces presentation on KYV-101 at ECTRIMS
PremiumThe Fly
Kyverna announces presentation on KYV-101 at ECTRIMS
4M ago
KYTX
PremiumCompany Announcements
Kyverna Therapeutics Announces Executive Leadership Changes
4M ago
8K
KYTX
Kyverna Therapeutics names Warner Biddle as CEO, succeeding Peter Maag
PremiumThe Fly
Kyverna Therapeutics names Warner Biddle as CEO, succeeding Peter Maag
4M ago
KYTX
Kyverna Therapeutics treatment of stiff person syndrome gets orphan designation
PremiumThe FlyKyverna Therapeutics treatment of stiff person syndrome gets orphan designation
5M ago
KYTX
Kyverna Therapeutics price target lowered to $7 from $8 at H.C. Wainwright
Premium
The Fly
Kyverna Therapeutics price target lowered to $7 from $8 at H.C. Wainwright
5M ago
KYTX
Kyverna Therapeutics reports Q2 EPS (67c), consensus (70c)
Premium
The Fly
Kyverna Therapeutics reports Q2 EPS (67c), consensus (70c)
5M ago
KYTX

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >